SCHEMBL29564375

SCHEMBL29564375

N#Cc1cccc(NCc2ccc(F)cc2)c1N1CCOCC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.44
HPGD P15428 2/20 0.44
HSD17B10 Q99714 2/20 0.44
TSHR P16473 1/20 0.44
GAA P10253 2/20 0.43
PIK3CA P42336 1/20 0.42
PIK3CB P42338 1/20 0.42
MAOB P27338 1/20 0.40
CTSL P07711 2/20 0.40
CTSS P25774 1/20 0.40
CTSK P43235 1/20 0.40
KMT2A Q03164 2/20 0.40
MAPT P10636 1/20 0.40
MEN1 O00255 1/20 0.40
ALDH1A1 P00352 2/20 0.40
LRRK2 Q5S007 2/20 0.39
LMNA P02545 2/20 0.39
TP53 P04637 1/20 0.39
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22274051 0.75 GAA (0.65) KDM4EHPGDHSD17B10TSHRGAA
SCHEMBL28873028 0.75 KDM4E (0.75) KDM4EHPGDHSD17B10TSHRGAA
SCHEMBL28131577 0.71 KDM4E (0.49) KDM4EHPGDHSD17B10TSHRGAA
SCHEMBL25302480 0.69 KDM4E (0.47) KDM4EHPGDHSD17B10TSHRKMT2A
SCHEMBL29564372 0.67 KDM4E (0.56) KDM4EHPGDHSD17B10TSHRGAA
SCHEMBL22279054 0.66 KDM4E (0.57) KDM4EHPGDHSD17B10TSHRGAA
SCHEMBL6695035 0.66 AURKA (0.50) KDM4EHPGDHSD17B10TSHRPIK3CA
SCHEMBL29456651 0.66 KDM4E (0.73) KDM4EHPGDHSD17B10TSHRGAA
SCHEMBL16122033 0.65 KDM4E (0.57) KDM4EHPGDHSD17B10TSHRKMT2A
SCHEMBL5593099 0.64 KMO (0.44) KDM4EHPGDHSD17B10TSHRKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109651297-B N-benzyl-N-aryl sulfonamide derivative and preparation and application thereof 杭州壹瑞医药科技有限公司 2022-05-27 CN disclosed